title: Perioperative fasting and the management of type 2 diabetes.
abstract: Type 2 diabetes is the most common form of diabetes, affecting approximately 90 per cent of people with the condition. The global incidence of diabetes is rising and the number of people affected is projected to exceed 300 million by the year 2025 (World Health Organization, 2003). Type 2 diabetes results from insulin resistance and/or a relative lack of insulin production. It is progressive and many patients may require dietary modifications, oral hypoglycaemic medication, and/or insulin to obtain good glycaemic control. Good control has been shown to reduce the complications of diabetes (UK Prospective Diabetes Study Group, 1998).
authors.affiliation: University of Central England, University Hospital Birmingham NHS Trust.
authors.forename: Theresa
authors.initials: T
authors.lastname: Smyth
mesh_terms: D000284:Administration, Oral; D003924:Diabetes Mellitus, Type 2 / Q000451:nursing*; D005215:Fasting; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage; D019990:Perioperative Care
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin